T. Zhao

发表

Development of glycinergic innervation to the murine LSO and SPN in the presence and absence of the MNTB

S. Altieri, T. Zhao, Walid Jalabi, 2014, Front. Neural Circuits..

Hereditary early-onset Parkinsonism : the role of the FBXO7 protein

T. Zhao, Tianna Zhao, 2012 .

Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15)

B. Oostra, R. Willemsen, T. Zhao, 2011, PloS one.

Identification of the Different Roles and Potential Mechanisms of T Isoforms in the Tumor Recurrence and Cell Cycle of Chordomas

T. Zhao, Liwei Zhang, Ke Wang, 2019, OncoTargets and therapy.

Translational Control of Myelin Basic Protein Expression by ERK2 MAP Kinase Regulates Timely Remyelination in the Adult Brain

T. Zhao, M. Karl, Sharyl L Fyffe-Maricich, 2015, The Journal of Neuroscience.

AZD8055 enhances in vivo efficacy of afatinib in chordomas

I. Siu, G. Gallia, M. Xia, 2019, The Journal of pathology.

International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System

C. Snyderman, G. Gallia, T. Fenton, 2022, Journal of Neurological Surgery Part B: Skull Base.

Dopaminergic neuronal loss and dopamine-dependent locomotor defects in Fbxo7-deficient zebrafish.

B. Oostra, R. Willemsen, T. Zhao, 2012 .

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome

W. Oyen, M. Horstink, B. Oostra, 2009, Neurology.

Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.

B. Oostra, G. Cossu, A. Federico, 2012, American journal of human genetics.

ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma

Yu Lin, T. Zhao, M. Lim, 2020, Theranostics.

Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model

A. Olivi, C. Eberhart, T. Zhao, 2021, PloS one.

Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors

C. Eberhart, T. Zhao, H. Brem, 2018, Oncotarget.

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Nils W. Engel, J. Fernandez-Miranda, R. West, 2021, European journal of cancer.

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma

Zev A. Binder, K. Kinzler, C. Bettegowda, 2018, Nature Communications.

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

Christopher M. Jackson, T. Zhao, Denis Routkevitch, 2021, Oncoimmunology.

FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.

B. Oostra, J. Kros, R. Willemsen, 2013, Journal of neuropathology and experimental neurology.

Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma

D. Sidransky, T. Zhao, H. Brem, 2020, Molecular Cancer Therapeutics.

En1 directs superior olivary complex neuron positioning, survival, and expression of FoxP1.

S. Altieri, T. Zhao, Walid Jalabi, 2015, Developmental biology.

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma

Zev A. Binder, K. Kinzler, C. Bettegowda, 2018, Nature Communications.

En1 is necessary for survival of neurons in the ventral nuclei of the lateral lemniscus

S. Altieri, T. Zhao, Walid Jalabi, 2016, Developmental neurobiology.